Provide guidance and assistance to stakeholders in the GMO product value chain
BSA provides guidance and assistance to stakeholders in the GMO product value chain to ensure compliance with the regulatory and biosafety requirements across all the stages of GMO research and development such as, contained use, field trials and commercial release. The platform aims to increase awareness and confidence in the national biotechnology innovation system, including the relevant governance systems.
Key Focus areas
BSA’s core business is to provide value-added services, support, and investments, aimed at enabling sustainable bio-innovation. These can be grouped into four distinct offerings:
- Biosafety/sustainability and risk analysis consultation, guidance, support, and capacity development offered to all stakeholders, to improve bio-innovation efficiency and compliance across all stages of bio-innovation research, development, and commercialisation, including contained use, confined field trials and commercial release.